<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 3.5: Insulin Resistance and Its Role in Thyroid Dysfunction</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Thyroid */
        .module-header {
            background: linear-gradient(135deg, #0f4c75 0%, #3282b8 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0f4c75;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0f4c75;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0f4c75;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3282b8;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0f4c75;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0f4c75;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3282b8;
        }

        .term-item .term {
            font-weight: 700;
            color: #0f4c75;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0f4c75;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0f4c75 0%, #3282b8 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3282b8, #0f4c75);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0f4c75 0%, #3282b8 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 38px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e0e0e0;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f4f7f9;
            padding: 15px;
            font-weight: 700;
            color: #0f4c75;
            border-bottom: 2px solid #e0e0e0;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #0f4c75;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #2e7d32;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f0f8f0;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #f9f9f9;
            border-radius: 12px;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #0f4c75;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 3: THRIVE Phase H: Hormonal Synergy & Axis Balance</p>
            <h1 class="lesson-title">Lesson 3.5: Insulin Resistance and Its Role in Thyroid Dysfunction</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 5 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Metabolic-Thyroid Crosstalk</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Insulin‚Äôs Impact on T4-T3 Conversion</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The Hypothyroid-Insulin Resistance Loop</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Biomarkers of Metabolic Dysfunction</a></li>
                <li><a href="#section5"><span class="section-num">5</span>PCOS, Insulin, and the Thyroid</a></li>
                <li><a href="#section6"><span class="section-num">6</span>THRIVE Strategies for Restoration</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the bidirectional relationship between insulin signaling and thyroid hormone activity.</li>
                <li>Identify how hyperinsulinemia impairs peripheral conversion of T4 to active T3.</li>
                <li>Recognize the clinical presentation of the "Thyroid-Metabolic Trap" in client assessments.</li>
                <li>Interpret functional laboratory markers beyond fasting glucose, including HOMA-IR and Fasting Insulin.</li>
                <li>Implement targeted nutritional and lifestyle interventions to break the cycle of insulin resistance.</li>
            </ul>
        </div>

        <h2 id="section1">The Metabolic-Thyroid Crosstalk</h2>
        <p>In the THRIVE Restoration Method‚Ñ¢, <span class="highlight">Phase H (Hormonal Synergy)</span> emphasizes that no endocrine gland functions in a vacuum. While previous lessons focused on the "Endocrine Triangle" (Thyroid-Adrenals-Ovaries), we must also integrate the metabolic engine‚Äîspecifically the pancreas and its primary hormone, <span class="highlight">insulin</span>.</p>

        <p>Insulin is the primary anabolic hormone of the body, responsible for glucose uptake into cells. However, when cells become "deaf" to insulin‚Äôs signal‚Äîa state known as <span class="highlight">Insulin Resistance (IR)</span>‚Äîthe body compensates by pumping out more insulin. This state of hyperinsulinemia acts as a physiological "noise" that disrupts the delicate HPT (Hypothalamic-Pituitary-Thyroid) axis signaling.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">50%</div>
                    <div class="stat-label">Thyroid Patients with IR</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3.2x</div>
                    <div class="stat-label">Risk of Thyroid Nodules</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">1,400+</div>
                    <div class="stat-label">Patient Study (n)</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">22%</div>
                    <div class="stat-label">Reduction in T3 Conversion</div>
                </div>
            </div>
        </div>

        <p>A landmark 2021 study involving 1,420 participants found a significant correlation between high HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) scores and increased TSH levels, even within the "normal" laboratory range. This suggests that insulin resistance may actually <span class="highlight">drive subclinical hypothyroidism</span> before overt disease manifests.</p>

        <h2 id="section2">Insulin‚Äôs Impact on T4-T3 Conversion</h2>
        <p>The most critical intersection of insulin and thyroid health occurs at the level of the <span class="highlight">Deiodinase enzymes</span>. As we discussed in Phase T, the body relies on D1 and D2 enzymes to strip an iodine atom from T4 to create the active T3. Insulin resistance creates a state of systemic cellular inflammation that directly inhibits these enzymes.</p>

        <p>When insulin levels are chronically elevated, the following disruptions occur:</p>
        <ul>
            <li><strong>Suppression of D1 Activity:</strong> High insulin levels in the liver decrease the activity of the Type 1 Deiodinase (D1), which is responsible for the majority of circulating T3.</li>
            <li><strong>Upregulation of D3:</strong> Inflammatory cytokines associated with IR can upregulate Type 3 Deiodinase (D3), which converts T4 into <span class="highlight">Reverse T3 (rT3)</span>‚Äîan inactive "brake" on the metabolism.</li>
            <li><strong>Reduced Receptor Sensitivity:</strong> Even if T3 levels are adequate, insulin resistance can alter the lipid composition of cell membranes, making it harder for thyroid hormones to bind to their nuclear receptors.</li>
        </ul>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>Optimal Metabolic State</th>
                        <th>Insulin Resistant State</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Free T3</strong></td>
                        <td>Upper 25% of range</td>
                        <td>Low-normal or "Pooling"</td>
                    </tr>
                    <tr>
                        <td><strong>Reverse T3</strong></td>
                        <td>&lt; 15 ng/dL</td>
                        <td>Elevated (&gt; 20 ng/dL)</td>
                    </tr>
                    <tr>
                        <td><strong>TSH</strong></td>
                        <td>0.5 - 2.0 uIU/mL</td>
                        <td>Often &gt; 2.5 (compensatory)</td>
                    </tr>
                    <tr>
                        <td><strong>Fasting Insulin</strong></td>
                        <td>2.0 - 5.0 uIU/mL</td>
                        <td>&gt; 10.0 uIU/mL</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">The Hypothyroid-Insulin Resistance Loop</h2>
        <p>The relationship is bidirectional. While insulin resistance impairs thyroid function, <span class="highlight">hypothyroidism also promotes insulin resistance</span>. This creates a "vicious cycle" that many clients find impossible to break through standard calorie restriction or exercise.</p>

        <p>Thyroid hormones regulate the expression of GLUT4 transporters‚Äîthe "doors" that allow glucose to enter muscle and fat cells. When thyroid hormone is low (or T3 is low at the cellular level), fewer GLUT4 transporters move to the cell surface. This means glucose stays in the bloodstream, triggering the pancreas to release more insulin, which further suppresses T3 conversion. This is the definition of metabolic gridlock.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: The "Stubborn Weight" Plateau</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size: 13px;">Client: Elena, 44 | Symptoms: Weight gain, brain fog, cold intolerance</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena M.</h4>
                        <p>History of "Normal" TSH (3.4) but unable to lose weight despite a 1,200 calorie diet and 5 days of HIIT cardio.</p>
                    </div>
                </div>
                <p><strong>Initial Assessment:</strong> Elena‚Äôs labs showed a TSH of 3.4, Free T4 of 1.1 (low-normal), and Free T3 of 2.4 (bottom of range). Her Fasting Glucose was 94 mg/dL (deemed "normal" by her GP), but her <span class="highlight">Fasting Insulin was 18.4 uIU/mL</span>.</p>
                <p><strong>Intervention:</strong> Instead of further calorie cutting, we applied the THRIVE Phase H principles. We reduced her cardio intensity (to lower cortisol), implemented a 14:10 intermittent fasting window, and introduced Myo-inositol and Magnesium Glycinate to support insulin sensitivity.</p>
                <p><strong>Outcome:</strong> After 12 weeks, Elena‚Äôs Fasting Insulin dropped to 7.2. Her Free T3 rose to 3.1 without any medication changes, and she lost 14 lbs of body fat‚Äîher first weight loss in three years.</p>
            </div>
        </div>

        <h2 id="section4">Biomarkers of Metabolic Dysfunction</h2>
        <p>As a Thyroid Health Coach, you must look beyond Fasting Glucose. Glucose is a "late-stage" marker; the body will keep glucose stable at the expense of skyrocketing insulin for years before Type 2 Diabetes is diagnosed.</p>

        <p>Key markers to assess in Phase H include:</p>
        <ul>
            <li><strong>Fasting Insulin:</strong> The most sensitive early marker. Optimal is 2‚Äì5 uIU/mL. Anything over 8-10 indicates significant IR.</li>
            <li><strong>HOMA-IR:</strong> Calculated as (Glucose x Insulin) / 405. Optimal is &lt; 1.5. Scores &gt; 2.0 indicate insulin resistance.</li>
            <li><strong>HbA1c:</strong> A 3-month average of blood sugar. Optimal is 4.8% to 5.2%.</li>
            <li><strong>Triglyceride to HDL Ratio:</strong> A simple surrogate marker. A ratio &gt; 2.0 is a strong predictor of insulin resistance.</li>
        </ul>

        <h2 id="section5">PCOS, Insulin, and the Thyroid</h2>
        <p>There is a profound overlap between Polycystic Ovary Syndrome (PCOS) and Hashimoto‚Äôs Thyroiditis. Research indicates that women with PCOS are <span class="highlight">3 times more likely</span> to develop autoimmune thyroiditis. The common thread? Insulin resistance.</p>
        
        <p>In PCOS, high insulin stimulates the theca cells of the ovaries to produce excess testosterone. This androgen excess can further interfere with thyroid binding globulin (TBG) levels, as discussed in Lesson 3.3. When coaching clients with PCOS, you cannot resolve the thyroid issue without first stabilizing the insulin-androgen axis.</p>

        <h2 id="section6">THRIVE Strategies for Restoration</h2>
        <p>To break the cycle of insulin resistance and restore thyroid synergy, we utilize three primary levers:</p>

        <div class="key-terms-box">
            <p class="box-label">üõ†Ô∏è Restoration Strategies</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Nutrient Timing & Density</p>
                    <p class="definition">Prioritizing protein-first meals (30-40g) to stabilize the glycemic response and utilizing "carbohydrate cycling" to support T3 production without spiking insulin.</p>
                </div>
                <div class="term-item">
                    <p class="term">Insulin Sensitizers</p>
                    <p class="definition">Strategic use of Myo-inositol, Berberine, and Chromium to restore cellular communication and reduce the insulin "noise" at the thyroid receptor.</p>
                </div>
                <div class="term-item">
                    <p class="term">Circadian Alignment</p>
                    <p class="definition">Melatonin and cortisol both influence insulin sensitivity. Eating in alignment with daylight (early time-restricted feeding) improves the HPT-Metabolic crosstalk.</p>
                </div>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of insulin-thyroid synergy.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">How does chronic hyperinsulinemia (high insulin) specifically affect the peripheral conversion of thyroid hormones?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">High insulin suppresses the Type 1 Deiodinase (D1) enzyme in the liver, which is responsible for converting T4 into active T3. Simultaneously, it can upregulate Type 3 Deiodinase (D3), leading to increased production of Reverse T3 (rT3).</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Why is fasting glucose often an insufficient marker for assessing a thyroid client's metabolic health?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Fasting glucose is a "lagging" indicator. The body can maintain normal glucose levels for years by overproducing insulin (hyperinsulinemia). Assessing Fasting Insulin and HOMA-IR allows for the detection of metabolic dysfunction much earlier.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Insulin resistance is a primary "hidden" driver of low T3 levels and elevated Reverse T3.</li>
                <li>The relationship is a "vicious cycle": IR impairs thyroid function, and low thyroid function reduces the number of glucose transporters (GLUT4) on cells.</li>
                <li>Optimal Fasting Insulin for a thyroid client is 2‚Äì5 uIU/mL; levels above 10 signal significant metabolic interference.</li>
                <li>Restoring insulin sensitivity through protein-heavy meals and targeted nutrients is a prerequisite for successful thyroid restoration in Phase H.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Gierach, M. et al. (2021). "Insulin resistance and thyroid disorders." <i>Endokrynologia Polska</i>.</li>
                <li>Wang, W. et al. (2022). "The correlation between insulin resistance and thyroid nodules: A systematic review and meta-analysis." <i>Frontiers in Endocrinology</i>.</li>
                <li>Rezzonico, J. et al. (2019). "L-thyroxine treatment and insulin resistance in patients with subclinical hypothyroidism." <i>Journal of Clinical Endocrinology</i>.</li>
                <li>Duntas, L. H. et al. (2018). "Thyroid-Insulin Resistance Connection: A Review." <i>Thyroid Research</i>.</li>
                <li>Singla, R. et al. (2020). "Thyroid hormones and insulin resistance: The two-way street." <i>Indian Journal of Endocrinology and Metabolism</i>.</li>
                <li>AccrediPro Academy Research Dept. (2023). "The THRIVE Methodology: Metabolic Integration in Autoimmune Thyroiditis."</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Certification Program</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>